Xylometazoline is a derivative of imidazoline. It has sympathomimetic activity. Application to the mucosa of the nose, causing constriction of blood vessels, swelling removes, inhibits hyperaemia of the mucosa of the nasopharynx and reduce the amount of mucus.
Before use of xylometazoline / XYLOMETAZOLINE 0.1%:
Do not use xylometazoline WZF 0,1% if reported to any of the following:
Known hypersensitivity to the active substance or to any of the excipients; Narrow-angle glaucoma; Hypophysectomy or other cranial intervention; Dry atrophic rhinitis (rhinitis sicca).
Use xylometazoline WZF 0,1% with caution:
In young children - if you experience agitation or sleep disorders drug should be discontinued;
In patients following administration of sympathomimetics were observed following symptoms: insomnia, dizziness, tremor, arrhythmias, or hypertension;
Patients c circulatory disorders (hypertension, angina), diabetes, glaucoma, prostatic hypertrophy, hyperthyroidism.
Patients with these conditions should consult a doctor before starting treatment with xylometazoline.
With continued use risk of atrophy of the nasal mucosa and therefore the application is limited to 7 days.
Special attention in certain special groups using drug
Use of xylometazoline in children:
Do not use in children under 2 years.
In children under 6 years old drug subject to medical prescription by prescription.
Pregnancy and lactation:
Due to the lack of landmark studies on the effects of the product on the fetus, and because it is not known whether the drug is excreted in human milk should not be used during pregnancy and lactation.
Drive and use machines:
The product is intended for short-term treatment, but prolonged use and high doses are not excluded systemic effects on the cardiovascular system, which may impair the ability to drive and use machines.
Important information about some ingredients of the product Xylometazoline
Due to the content of benzalkonium chloride drug can cause local irritation of the nasal mucosa.
Using other medicines:
Do not apply the preparation during treatment with tricyclic antidepressants or MAO inhibitors (drugs used to treat depression) due to reports of rare cases of interactions. Concomitant use of other sympathomimetic agents (ephedrine, pseudoephedrine) should be avoided. Please tell your doctor if you are taking or have recently taken any other medicines, even those not you been prescribed.